Last reviewed · How we verify

PET Scan with [18F] VAT

Stony Brook University · FDA-approved active Small molecule

PET Scan with [18F] VAT is a PET imaging agent / Radiopharmaceutical Small molecule drug developed by Stony Brook University. It is currently FDA-approved for PET imaging of vascular inflammation and atherosclerotic disease, Assessment of endothelial activation in cardiovascular disease.

[18F] VAT is a fluorine-18 labeled positron emission tomography (PET) imaging agent that binds to vascular adhesion molecules to visualize inflammation and vascular pathology.

[18F] VAT is a fluorine-18 labeled positron emission tomography (PET) imaging agent that binds to vascular adhesion molecules to visualize inflammation and vascular pathology. Used for PET imaging of vascular inflammation and atherosclerotic disease, Assessment of endothelial activation in cardiovascular disease.

At a glance

Generic namePET Scan with [18F] VAT
SponsorStony Brook University
Drug classPET imaging agent / Radiopharmaceutical
TargetVascular adhesion molecules (VAM)
ModalitySmall molecule
Therapeutic areaDiagnostic Imaging / Nuclear Medicine
PhaseFDA-approved

Mechanism of action

[18F] VAT (likely a vascular adhesion molecule targeting agent) is a radiopharmaceutical designed for PET imaging that uses fluorine-18 as the radioactive tracer. It accumulates at sites of vascular inflammation and endothelial activation by binding to adhesion molecules expressed on activated endothelium. This allows non-invasive visualization and quantification of inflammatory vascular disease burden.

Approved indications

Common side effects

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about PET Scan with [18F] VAT

What is PET Scan with [18F] VAT?

PET Scan with [18F] VAT is a PET imaging agent / Radiopharmaceutical drug developed by Stony Brook University, indicated for PET imaging of vascular inflammation and atherosclerotic disease, Assessment of endothelial activation in cardiovascular disease.

How does PET Scan with [18F] VAT work?

[18F] VAT is a fluorine-18 labeled positron emission tomography (PET) imaging agent that binds to vascular adhesion molecules to visualize inflammation and vascular pathology.

What is PET Scan with [18F] VAT used for?

PET Scan with [18F] VAT is indicated for PET imaging of vascular inflammation and atherosclerotic disease, Assessment of endothelial activation in cardiovascular disease.

Who makes PET Scan with [18F] VAT?

PET Scan with [18F] VAT is developed and marketed by Stony Brook University (see full Stony Brook University pipeline at /company/stony-brook-university).

What drug class is PET Scan with [18F] VAT in?

PET Scan with [18F] VAT belongs to the PET imaging agent / Radiopharmaceutical class. See all PET imaging agent / Radiopharmaceutical drugs at /class/pet-imaging-agent-radiopharmaceutical.

What development phase is PET Scan with [18F] VAT in?

PET Scan with [18F] VAT is FDA-approved (marketed).

What are the side effects of PET Scan with [18F] VAT?

Common side effects of PET Scan with [18F] VAT include Radiation exposure, Allergic reaction to tracer.

What does PET Scan with [18F] VAT target?

PET Scan with [18F] VAT targets Vascular adhesion molecules (VAM) and is a PET imaging agent / Radiopharmaceutical.

Related